未登录

V

Virginia Tzankova

Medical University Sofia

H指数:18

被引数:1,051

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Synthesis of Comb-like and Coil-Comb Polystyrene–Polyglycidol Copolymers via Click Chemistry: Self-Assembly and Biological Evaluation

通过点击化学合成梳状和螺旋-梳状聚苯乙烯-聚缩水甘油醇共聚物：自组装与生物评价

IF4.9

2026-02-260

OAAI

Oxidative stress in neurodegeneration: in vitro models for investigating cellular damage and neuroprotective strategies

神经退行性病变中的氧化应激：体外模型在细胞损伤和神经保护策略研究中的应用

IF1.1

2025-11-240

OAAI

Carboxylated Mesoporous Carbon Nanoparticles as Bicalutamide Carriers with Improved Biopharmaceutical and Chemo-Photothermal Characteristics

羧基化介孔碳纳米粒子作为比卡鲁胺载体，具有改善的生物药剂学和化疗-光热特性

IF0

2025-07-220

OA

Formulation of Caffeine-Hydroxypropyl-β-Cyclodextrin Complex in Hydrogel for Skin Treatment

咖啡因-羟丙基-β-环糊精复合物在水凝胶中的制备及其在皮肤治疗中的应用

IF5.3

2025-04-270

OA

Ophthalmic In Situ Nanocomposite Gel for Delivery of a Hydrophobic Antioxidant

IF5.3

2025-02-020

OAAI

Double Encapsulation of Resveratrol and Doxorubicin in Composite Nanogel-An Opportunity to Reduce Cardio- and Neurotoxicity of Doxorubicin

IF5.3

2024-10-282

OAAI

A novel combinatory treatment against a CDDP-resistant non-small cell lung cancer based on a Ruthenium(II)-cyclopentadienyl compound

PHARMACOLOGICAL RESEARCH

IF10.5

2024-10-010

OAAI

Composite Hydrogel with Oleic Acid-Grafted Mesoporous Silica Nanoparticles for Enhanced Topical Delivery of Doxorubicin

IF5.3

2024-05-223

OAAI

Incorporation of Resveratrol-Hydroxypropyl-β-Cyclodextrin Complexes into Hydrogel Formulation for Wound Treatment

IF5.3

2024-05-187

OAAI

Agar Graft Modification with Acrylic and Methacrylic Acid for the Preparation of pH-Sensitive Nanogels for 5-Fluorouracil Delivery

IF5.3

2024-02-231

OAAI

Formulation of Budesonide-Loaded Polymeric Nanoparticles into Hydrogels for Local Therapy of Atopic Dermatitis

IF5.3

2024-01-2010

OAAI

Thermosensitive Hydrogel-Functionalized Mesoporous Silica Nanoparticles for Parenteral Application of Chemotherapeutics

IF5.3

2023-09-218

OAAI

Synthesis, DFT Study, and In Vitro Evaluation of Antioxidant Properties and Cytotoxic and Cytoprotective Effects of New Hydrazones on SH-SY5Y Neuroblastoma Cell Lines

PHARMACEUTICALS

IF4.8

2023-08-235

OAAI

Design, Synthesis, In Silico Studies and In Vitro Evaluation of New Indole- and/or Donepezil-like Hybrids as Multitarget-Directed Agents for Alzheimer's Disease

PHARMACEUTICALS

IF4.8

2023-08-2211

OAAI

Incorporation of Resveratrol in Polymeric Nanogel for Improvement of Its Protective Effects on Cellular and Microsomal Oxidative Stress Models

IF5.3

2023-05-305

OAAI

Doxorubicin and Quercetin Double Loading in Modified MCM-41 Lowered Cardiotoxicity in H9c2 Cardioblast Cells In Vitro

BIOENGINEERING-BASEL

IF3.7

2023-05-242

OAAI

Double-Loaded Doxorubicin/Resveratrol Polymeric Micelles Providing Low Toxicity on Cardiac Cells and Enhanced Cytotoxicity on Lymphoma Cells

IF5.5

2023-04-1912

OAAI

In Silico Evaluation and In Vitro Determination of Neuroprotective and MAO-B Inhibitory Effects of Pyrrole-Based Hydrazones: A Therapeutic Approach to Parkinson's Disease

基于吡咯的hydr的神经保护和mao-b抑制作用的计算机评估和体外测定: 帕金森氏病的治疗方法

IF4.6

2022-12-0217

OAAI

Formulation of Nanomicelles Loaded with Cannabidiol as a Platform for Neuroprotective Therapy

IF5.5

2022-11-288

OAAI

Evaluation of the combined activity of benzimidazole arylhydrazones as new anti-Parkinsonian agents: monoamine oxidase-B inhibition, neuroprotection and oxidative stress modulation

NEURAL REGENERATION RESEARCH

IF6.7

2021-01-0122

OAAI